Colon Polyps: Prevalence Rates, Incidence Rates, and Growth Rates

Colonoscopy: Principles and Practice, Second Edition

Volumn , Issue , 2009, Pages 358-378

  Hofstad, Bjørn ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adenoma prevalence risk factors; Adenomas precursors in colorectal cancers; Age and sex related prevalence of adenomas; Colon polyps prevalence, incidence, and growth rates; Hereditary nonpolyposis colorectal cancer (HNPCC); Lilly screening colonoscopy study in Indianapolis and colorectal adenoma incidence rate; Nutrient effects on polyp growth; Polyp incidence risk factors (post polypectomy); Polyp recurrence and dietary factors, micronutrients and chemotherapeutic effects; Size, dysplasia, and villous structure

Indexed keywords

EID: 84889621357     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444316902.ch28     Document Type: Chapter

References (193)

1. Esmarch F. Die Krankenheiten Des Mastdarmes und Des Aftes. Bd 48 edn. Stuttgart: Deutsche Chirurgie, 1887.
2. Hoff G, Foerster A, Vatn MH, Sauar J, Larsen S. Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. Scand J Gastroenterol 1986; 21: 853-62.
3. Bremner CG, Ackerman LV. Polyps and carcinoma of the large bowel in the South African Bantu. Cancer 1970; 26: 991-9.
4. Correa P, Duque E, Cuello C, Haenszel W. Polyps of the colon and rectum in Cali, Colombia. Int J Cancer 1972; 9: 86-96.
5. Clark JC, Collan Y, Eide TJ, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large bowel cancer. Int J Cancer 1985; 36: 179-86.
6. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982; 49: 819-25.
7. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-70.
8. Shinya H, Wolff WI. Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Surg 1979; 190: 679-83.
9. Hermanek P. Dysplasia-carcinoma sequence, types of adenomas and early colo-rectal carcinoma. Eur J Surg Oncol 1987; 13: 141-3.
10. Bedenne L, Faivre J, Boutron MC, Piard F, Cauvin JM, Hillon P. Adenoma-carcinoma sequence or "de novo" carcinogenesis. Cancer 1992; 69: 883-8.
11. Hoff G, Vatn M. Epidemiology of polyps in the rectum and sigmoid colon. Endoscopic evaluation of size and localization of polyps. Scand J Gastroenterol 1985; 20: 356-60.
12. Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the frequency and size of polyps missed by colonoscopy. J Natl Cancer Inst 1990; 82: 1769-72.
13. Rex D, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-8.
14. Hofstad B, Vatn M, Norheim Andersen S, et al. Growth of colorectal polyps: recovery and evaluation of unresected polyps for a period of 3 years. Gut 1996; 39: 449-56.
15. Hasson J, Schneiderman H. Autopsy training programs. To right a wrong. Arch Pathol Lab Med 1995; 119: 289-91.
16. Stemmermann GN, Yatani R. Diverticulosis and polyps of the large intestine. A necropsy study of Hawaii Japanese. Cancer 1973; 31: 1260-70.
17. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 1979; 43: 1847-57.
18. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982; 23: 835-42.
19. Helwig EB. The evolution of adenomas of the large intestine and their relation to carcinoma. Surg Gynecol Obstet 1947; 84: 36-49.
20. Sato E, Ouchi A, Sasano N, Ishidate T. Polyps and diverticulosis of large bowel in autopsy population of Akita prefecture, compared with Miyagi. High risk for colorectal cancer in Japan. Cancer 1976; 37: 1316-21.
21. Correa P, Strong JP, Reif A, Johnson WD. The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer 1977; 39: 2258-64.
22. Coode PE, Chan KW, Chan YT. Polyps and diverticula of the large intestine: a necropsy survey in Hong Kong. Gut 1985; 26: 1045-8.
23. Swarbrick ET, Fevre DI, Hunt RH, Thomas BM, Williams CB. Colonoscopy for unexplained rectal bleeding. Br Med J 1978; 2: 1685-7.
24. Abrams JS. A second look at colonoscopy: indications, failures, and costs. Arch Surg 1982; 117: 913-17.
25. Aldridge MC, Sim AJ. Colonoscopy findings in symptomatic patients without X-ray evidence of colonic neoplasms. Lancet 1986; ii: 833-4.
26. Goulston KJ, Cook I, Dent OF. How important is rectal bleeding in the diagnosis of bowel cancer and polyps? Lancet 1986; ii: 261-5.
27. Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100: 64-7.
28. Neugut AI, Jacobson JS, Rella VA. Prevalence and incidence of colorectal adenomas and cancer in asymptomatic persons. Gastrointest Endosc Clin North Am 1997; 7: 387-99.
29. Lieberman DA, Smith FW. Frequency of isolated proximal colonic polyps among patients referred for colonoscopy. Arch Intern Med 1988; 148: 473-5.
30. DiSario JA, Foutch PG, Mai HD, Pardy K, Manne RK. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 1991; 86: 941-5.
31. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991; 86: 946-51.
32. Foutch PG, Mai H, Pardy K, DiSario JA, Manne RK, Kerr D. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average risk men. Dig Dis Sci 1991; 36: 924-8.
33. Betés Ibáñez M, Muñoz-Navas MA, Duque JM, et al. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy. Gastrointest Endosc 2004; 59: 634-41.
34. Senore C, Segnan N, Bonelli L, et al. Predicting proximal advanced neoplasms at screening sigmoidoscopy. Dis Colon Rectum 2004; 47: 1331-40.
35. Schoen RE, Weissfeld JL, Pinsky PF, Riley T. Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy. Gastroenterology 2006; 131: 2006-9.
36. Kim WH, Lee SK, Chung JH, Cho YS, Yoo HM, Kang JK. Significance of rectosigmoid polyp as a predictor of proximal colonic polyp. Yonsei Med J 2000; 41: 98-106.
37. Erdem L, Akbayir N, Yildirim S, et al. Predictive value of morphologic characteristics in rectosigmoid adenomatous polyps for the probability of synchronous polyps or cancer in the proximal colon. Turk J Gastroenterol 2005; 16: 207-11.
38. Yoshinaga M, Watabe R, Takeda H, et al. Subjects older than 60 years with negative findings on sigmoidoscopy should still undergo colonoscopy. Hepatogastroenterology 2002; 49: 668-71.
39. Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol 2005; 3: 798-805.
40. Brady PG, Straker RJ, McClave SA, Nord HJ, Pinkas M, Robinson BE. Are hyperplastic rectosigmoid polyps associated with an increased risk of proximal colonic neoplasms? Gastrointest Endosc 1993; 39: 481-5.
41. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. Lifestyle-related risk factors and chemoprevention for colorectal neoplasia: experience from the large-scale NORCCAP screening trial. Eur J Cancer Prev 2005; 14: 373-9.
42. Hoff G, Vatn M, Gjone E, Larsen S, Sauar J. Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study. Scand J Gastroenterol 1985; 20: 351-5.
43. Cappell MS. From colonic polyps to colon cancer: pathophysiology, clinical presentation, screening and colonoscopic therapy. Minerva Gastroenterol Dietol 2007; 53: 351-73.
44. Kim DH, Lee SY, Choi KS, et al. The usefulness of colonoscopy as a screening test for detecting colorectal polyps. Hepatogastroenterology 2007; 54: 2240-2.
45. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cance. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343: 162-8.
46. Guillem JG, Forde KA, Treat MR, Neugut AI, O'Toole KM, Diamond BE. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992; 35: 523-9.
47. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years. Gut 1999; 45: 834-9.
48. Rex DK, Lehman GA, Ulbright TM, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993; 88: 825-31.
49. Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005; 352: 2061-8.
50. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-72.
51. Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 2007; 56: 1585-9.
52. Marigo C, Correa P, Haenszel W. Cancer and "cancer related" colorectal lesions in Sao Paulo, Brazil. Int J Cancer 1978; 22: 645-54.
53. Greene FL. Distribution of colorectal neoplasms. A left to right shift of polyps and cancer. Am Surg 1983; 49: 62-5.
54. Eide TJ. The age-, sex-, and site-specific occurrence of adenomas and carcinomas of the large intestine within a defined population. Scand J Gastroenterol 1986; 21: 1083-8.
55. Levi F, Randimbison L, La Vecchia C. Trends in subsite distribution of colorectal cancers and polyps from the Vaud Cancer Registry. Cancer 1993; 72: 46-50.
56. O'Brien MJ, Winawer SJ, Zauber AG et al. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98: 371-9.
57. Matek W, Guggenmoos-Holzmann I, Demling L. Follow-up of patients with colorectal adenomas. Endoscopy 1985; 17: 175-81.
58. Waye JD. The development of carcinoma of the colon. Am J Gastroenterol 1977; 67: 427-9.
59. Eide TJ, Stalsberg H. Polyps of the large intestine in Northern Norway. Cancer 1978; 42: 2839-48.
60. Williams GT, Arthur JF, Bussey HJ, Morson BC. Metaplastic polyps and polyposis of the colorectum. Histopathology 1980; 4: 155-70.
61. Togashi K, Konishi F, Ishizuka T, Sato T, Senba S, Kanazawa K. Efficacy of magnifying endoscopy in the differential diagnosis of neoplastic and non-neoplastic polyps of the large bowel. Dis Colon Rectum 1999; 42: 1602-8.
62. Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 2000; 356: 1300-6.
63. Eide TJ, Schweder T. Clustering of adenomas in the large intestine. Gut 1984; 25: 1262-7.
64. Cappell MS, Forde KA. Spatial clustering of multiple hyperplastic, adenomatous, and malignant colonic polyps in individual patients. Dis Colon Rectum 1989; 32: 641-52.
65. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 1988; 319: 533-7.
66. Bazzoli F, Fossi S, Sottili S, et al. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology 1995; 109: 783-8.
67. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996; 334: 82-7.
68. Hoff G, Vatn MH, Larsen S. Relationship between tobacco smoking and colorectal polyps. Scand J Gastroenterol 1996; 22: 13-16.
69. Kikendall JW, Bowen PE, Burgess MB, Magnetti C, Woodward J, Langenberg P. Cigarettes and alcohol as independent risk factors for colonic adenomas. Gastroenterology 1989; 97: 660-7.
70. Terry MB, Neugut AI. Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox. Am J Epidemiol 1998; 147: 903-10.
71. Almendingen K, Hofstad B, Trygg K, Hoff G, Hussain A, Vatn M. Smoking and colorectal adenomas: a case-control study. Eur J Cancer Prev 2000; 9: 193-203.
72. Anderson JC, Attam R, Alpern Z, et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol 2003; 98: 2777-83.
73. Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol 2006; 6: 5.
74. Boutron MC, Faivre J, Dop MC, Quipourt V, Senesse P. Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol 1995; 141: 1038-46.
75. Longnecker MP, Chen MJ, Probst-Hensch NM, et al. Alcohol and smoking in relation to the prevalence of adenomatous colorectal polyps detected at sigmoidoscopy. Epidemiology 1996; 7: 275-80.
76. Almendingen K, Hofstad B, Vatn MH. Does intake of alcohol increase the risk of presence and growth of colorectal adenomas followed-up in situ for three years? Scand J Gastroenterol 2002; 37: 80-7.
77. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005; 294: 914-23.
78. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994; 121: 241-6.
79. Chan AT, Giovannucci EL, Schernhammer ES, et al. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med 2004; 140: 157-66.
80. Rostom A, Dubé C, Lewin G, et al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007; 146: 376-89.
81. Giovannucci E, Stampfer MJ, Colditz G, Rimm EB, Willett WC. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst 1992; 84: 91-8.
82. Hoff G, Moen IE, Trygg K, et al. Epidemiology of polyps in the rectum and sigmoid colon. Evaluation of nutritional factors. Scand J Gastroenterol 1986; 21: 199-204.
83. Sandler RS, Lyles CM, Peipins LA, McAuliffe CE, Woosley JT, Kupper LT. Diet and risk of colorectal adenomas: macronutrients, cholesterol, and fiber. J Natl Cancer Inst 1993; 85: 884-91.
84. Almendingen K, Hofstad B, Vatn M. Does high body fatness increase risk of presence and growth of colorectal adenomas? A case-control study. Am J Gastroenterol 2001; 96: 2238-46.
85. Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol 2006; 6: 5.
86. Mathew A, Peters U, Chatterjee N, Kulldorff M, Sinha R. Fat, fiber, fruits, vegetables, and risk of colorectal adenomas. Int J Cancer 2004; 108: 287-92.
87. Sedjo RL, Byers T, Levin TR, et al. Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2007; 16: 526-31.
88. Shin A, Shrubsole MJ, Ness RM, et al. Meat and meat-mutagen intake, doneness preference and the risk of colorectal polyps: the Tennessee Colorectal Polyp Study. Int J Cancer 2007; 121: 136-42.
89. Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 2005; 97: 906-16.
90. Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol 2006; 6: 5.
91. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98: 920-31.
92. Benito E, Cabeza E, Moreno V, Obrador A, Bosch FX. Diet and colorectal adenomas: a case-control study in Majorca. Int J Cancer 1993; 55: 213-19.
93. Peters U, Sinha R, Chatterjee N, et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003; 361: 1491-5.
94. Austin GL, Adair LS, Galanko JA, Martin CF, Satia JA, Sandler RS. A diet high in fruits and low in meats reduces the risk of colorectal adenomas. J Nutr 2007; 137: 999-1004.
95. Agurs-Collins T, Smoot D, Afful J, Makambi K, Adams-Campbell LL. Legume intake and reduced colorectal adenoma risk in African-Americans. J Natl Black Nurses Assoc 2006; 17: 6-12.
96. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer 2007; 109: 510-17.
97. Neugut AI, Garbowski GC, Lee WC, et al. Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps. Ann Intern Med 1993; 118: 91-5.
98. Macquart-Moulin G, Riboli E, Cornee J, Kaaks R, Berthezene P. Colorectal polyps and diet: a case-control study in Marseilles. Int J Cancer 1987; 40: 179-88.
99. Boutron MC, Senesse P, Faivre J. Nutrients and adenoma size. Gastroenterology 1996; 110: A494.
100. Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 2005; 97: 684-92.
101. Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, Marshall JR. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer 2006; 118: 1777-81.
102. Jacobs ET, Jiang R, Alberts DS, et al. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst 2004; 96: 1669-75.
103. Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, Marshall JR. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer 2006; 118: 1777-81.
104. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer 2007; 109: 510-17.
105. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev 2005; 14: 525-8.
106. Shaukat A, Scouras N, Schünemann HJ. Role of supplemental calcium in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2005; 100: 390-4.
107. Grau MV, Baron JA, Sandler RS, et al. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst 2007; 99: 129-36.
108. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297: 2351-9.
109. Purdue MP, Mink PJ, Hartge P, Huang WY, Buys S, Hayes RB. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Cancer Causes Control 2005; 16: 965-73.
110. Wark PA, Van der Kuil W, Ploemacher J, et al. Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas. Int J Cancer 2006; 119: 398-405.
111. Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003; 290: 2959-67.
112. Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a metaanalysis of cohort studies. World J Gastroenterol 2007; 13: 4199-206.
113. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006; 17: 145-56.
114. Buc E, Kwiatkowski F, Alves A, Panis Y, Mantion G, Slim K. Tobacco smoking: a factor of early onset of colorectal cancer. Dis Colon Rectum 2006; 49: 1893-6.
115. Henry LG, Condon RE, Schulte WJ, Aprahamian C, DeCosse JJ. Risk of recurrence of colon polyps. Ann Surg 1975; 182: 511-15.
116. Waye JD, Braunfeld S. Surveillance intervals after colonoscopic polypectomy. Endoscopy 1982; 14: 79-81.
117. Morson BC, Bussey HJR. Magnitude of risk for cancer in patients with colorectal adenomas. Br J Surg 1985; 72(Suppl.): S23-S28.
118. Neugut AI, Johnsen CM, Forde KA, Treat MR. Recurrence rates for colorectal polyps. Cancer 1985; 55: 1586-9.
119. Wegener M, Borsch G, Schmidt G. Colorectal adenomas. Distribution, incidence of malignant transformation, and rate of recurrence. Dis Colon Rectum 1986; 29: 383-7.
120. Kronborg O, Fenger C. Prognostic evaluation of planned followup in patients with colorectal adenomas. An interim report. Int J Colorectal Dis 1987; 2: 203-7.
121. Holtzman R, Poulard J-B, Bank S, et al. Repeat colonoscopy after endoscopic polypectomy. Dis Colon Rectum 1987; 30: 185-8.
122. Nava H, Carlsson G, Petrelli NJ, Herrera L, Mittelman A. Followup colonoscopy in patients with colorectal adenomatous polyps. Dis Colon Rectum 1987; 30: 465-8.
123. Olsen HW, Lawrence WA, Snook CW, Mutch WM. Risk factors and screening techniques in 500 patients with benign and malignant colon polyps. Dis Colon Rectum 1988; 31: 216-21.
124. Eckardt VF, Fuchs M, Kanzler G, Remmele W, Stienen U. Follow-up of patients with colonic polyps containing severe atypia and invasive carcinoma. Compliance, recurrence, and survival. Cancer 1988; 61: 2552-7.
125. McKeown-Eyssen GE, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 1988; 48: 4701-5.
126. Yashiro K, Nagasako K, Sato S, Suzuki S, Obata H. Follow-up after polypectomy of colorectal adenomas. The importance of total colonoscopy. Surg Endosc 1989; 3: 87-91.
127. Woolfson IK, Eckholdt GJ, Wetzel CR, et al. Usefulness of performing colonoscopy one year after endoscopic polypectomy. Dis Colon Rectum 1990; 33: 389-93.
128. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993; 328: 901-6.
129. Triantafyllou K, Papatheodoridis GV, Paspatis GA, Vasilakaki TH, Elemenoglou I, Karamanolis DG. Predictors of the early development of advanced metachronous colon adenomas. Hepatogastroenterology 1997; 44: 533-8.
130. van Stolk RU, Beck GJ, Baron JA, Haile R, Summers R. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology 1998; 115: 13-18.
131. Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a highfiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians Network. N Engl J Med 2000; 342: 1156-62.
132. Noshirwani KC, van Stolk RU, Rybicki LA, Beck GJ. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 2000; 51: 433-7.
133. Riff ER, Dehaan K, Garewal GS. The role of sigmoidoscopy for asymptomatic patients. Results of three annual screening sigmoidoscopies, polypectomy, and subsequent surveillance colonoscopy in a primary-care setting. Cleve Clin J Med 1990; 57: 131-6.
134. Brint SL, DiPalma JA, Herrera JL. Colorectal cancer screening: is one-year surveillance sigmoidoscopy necessary? Am J Gastroenterol 1993; 88: 2019-21.
135. Maule WF. Screening for colorectal cancer by nurse endoscopists. N Engl J Med 1994; 330: 183-7.
136. Krevsky B, Fisher RS. Yield of rescreening for colonic polyps using flexible sigmoidoscopy Am J Gastroenterol 1994; 89: 1165-8.
137. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Hawes RH. The yield of a second screening flexible sigmoidoscopy in averagerisk persons after one negative examination. Gastroenterology 1994; 106: 593-5.
138. Platell CF, Philpott G, Olynyk JK. Flexible sigmoidoscopy screening for colorectal neoplasia in average-risk people: evaluation of a five-year rescreening interval. Med J Aust 2002; 176: 371-3.
139. Hixson LJ, Fennerty MB, Sampliner RE, McGee DL, Garewal H. Two-year incidence of colon adenomas developing after tandem colonoscopy. Am J Gastroenterol 1994; 89: 687-91.
140. Squillace S, Berggreen P, Jaffe P, et al. A normal initial colonoscopy after age 50 does not predict a polyp-free status for life. Am J Gastroenterol 1994; 89: 1156-9.
141. Neugut AI, Jacobson JS, Ahsan H, et al. Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology 1995; 108: 402-8.
142. Rex DK, Cummings OW, Helper DJ, et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic averagerisk persons. Gastroenterology 1996; 111: 1178-81.
143. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH. The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up. Am J Gastroenterol 2001; 96: 1901-7.
144. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008; 359: 1218-24.
145. Schoen RE, Pinsky PF, Weissfeld JL, et al. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 2003; 290: 41-8.
146. Burke CA, Elder K, Lopez R. Screening for colorectal cancer with flexible sigmoidoscopy: is a 5-yr interval appropriate? A comparison of the detection of neoplasia 3 yr versus 5 yr after a normal examination. Am J Gastroenterol 2006; 101: 1329-32.
147. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006; 130: 1872-85.
148. Kronborg O, Hage E, Adamsen S, Deichgraeber E. Follow-up after colorectal polypectomy. II. Repeated examinations of the colon every 6 months after removal of sessile adenomas and adenomas with the highest degrees of dysplasia. Scand J Gastroenterol 1983; 18: 1095-9.
149. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95.
150. Jacobsen JS, Neugut AI, Murray T, et al. Cigarette smoking and other behavioral risk factors for recurrence of colorectal adenomatous polyps (New York City, NY, USA). Cancer Causes Control 1994; 5: 215-20.
151. DeCosse JJ, Adams MB, Kuzuma JF, LoGerfo P, Condon RE. Effect of ascorbic acid on rectal polyps of patients with familial polyposis. Surgery 1975; 78: 608-12.
152. Bussey HJR, DeCosse JJ, Deschner EE, et al. A randomized trial of ascorbic acid in polyposis coli. Cancer 1982; 50: 1434-9.
153. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983; 24: 83-7.
154. Waddell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for polyposis of the colon. Am J Surg 1989; 157: 175-9.
155. Nugent KP, Farmer KCR, Spiegelman AD, Williams CB, Phillips RKS. Randomized controlled trial of the effect of sulindac and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 1618-19.
156. Grau MV, Baron JA, Barry EL, et al. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2005; 14: 2353-8.
157. Bertagnolli MM, Eagle CJ, Zauber AG, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006; 355: 873-84.
158. Tangrea JA, Albert PS, Lanza E, et al. Non-steroidal antiinflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control 2003; 14: 403-11.
159. Arber N, Eagle CJ, Spicak J, et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006; 355: 885-95.
160. Sansbury LB, Bergen AW, Wanke KL, et al. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 494-501.
161. Robertson DJ, Sandler RS, Haile R, et al. Fat, fiber, meat and the risk of colorectal adenomas. Am J Gastroenterol 2005; 100: 2789-95.
162. Kimura Y, Kono S, Toyomura K, et al. Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci 2007; 98: 590-7.
163. Lanza E, Hartman TJ, Albert PS, et al. High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial. J Nutr 2006; 136: 1896-903.
164. Roncucci L, Di Donato P, Carati L, et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dis Colon Rectum 1993; 36: 227-34.
165. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994; 331: 141-7.
166. Togashi K, Shimura K, Konishi F, et al. Prospective observation of small adenomas in patients after colorectal cancer surgery through magnification chromocolonoscopy. Dis Colon Rectum 2008; 51: 196-201.
167. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
168. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarthy RL. Natural history of untreated colonic polyps. Gastroenterology 1987; 93: 1009-13.
169. Waye JD, Lewis BS, Frankel A, Geller SA. Small colon polyps. Am J Gastroenterol 1988; 83: 120-2.
170. Loeve F, Boer R, Zauber AG, et al. National Polyp Study data: evidence for regression of adenomas. Int J Cancer 2004; 111: 633-9.
171. Margulies C, Krevsky B, Catalano MF. How accurate are endoscopic estimates of size? Gastrointest Endosc 1994; 40: 174-7.
172. Fennerty MB, Davidson J, Emerson SS, Sampliner RE, Hixson LJ, Garewal HS. Are endoscopic measurements of colonic polyps reliable? Am J Gastroenterol 1993; 88: 496-500.
173. Vakil N, Smith W, Bourgeois K, Everbach EC, Knyrim K. Endoscopic measurement of lesion size: improved accuracy with image processing. Gastrointest Endosc 1994; 40: 178-83.
174. Morales TG, Sampliner RE, Garewal HS, Fennerty MB, Aickin M. The difference in colon polyp size before and after removal. Gastrointest Endosc 1996; 43: 25-8.
175. Margulies C, Schoen RE, Gerber LD, Weissfeld JL. Inaccurate polyp size estimation can affect patient management. Endoscopic estimates of polyp size should be abandoned in favor of the pathologist's measurement. Gastrointest Endosc 1996; 43: 368.
176. Shenoy V, Chourdhry U, Gopalswamy N, et al. Is in vivo measurement of size of polyps during colonoscopy accurate? Gastrointest Endosc 1996; 43: 371.
177. Hofstad B, Vatn M, Larsen S, Osnes M. Reliability of in situ measurements of colorectal polyps. Scand J Gastroenterol 1992; 27: 59-64.
178. Hofstad B, Vatn M, Larsen S, Huitfeldt HS, Osnes M. In situ measurement of colorectal polyps to compare video and fiberoptic endoscopes. Endoscopy 1994; 26: 461-5.
179. Gopalswamy N, Shenoy VN, Choudhry U, et al. Is in vivo measurement of size of polyps during colonoscopy accurate? Gastrointest Endosc 1997; 46: 497-502.
180. Knoernschild HE. Growth rate and malignant potential of colonic polyps: early results. Surg Forum 1963; 14: 137-8.
181. Hofstad B, Vatn M, Hoff G, Larsen S, Osnes M. Growth of colorectal polyps. Design of a prospective, randomized, placebo controlled intervention study in patients with colorectal polyps. Eur J Cancer Prev 1992; 1: 415-22.
182. Kronborg O, Hage E, Deichgraeber E. The clean colon. Scand J Gastroenterol 1981; 16: 879-84.
183. Hofstad B, Vatn M, Larsen S, Osnes M. Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 MM, 1 year after detection. Scand J Gastroenterol 1994; 29: 640-5.
184. Hyman N, Waye JD. Endoscopic four quadrant tattoo for the identification of colonic lesions at surgery. Gastrointest Endosc 1991; 37: 56-8.
185. Park SI, Genta RS, Romeo DP, Weesner RE. Colonic abscess and focal peritonitis secondary to india ink tattooing of the colon. Gastrointest Endosc 1991; 37: 68-71.
186. Coman E, Brandt LJ, Brenner S, Sablay B, Bennet B. Fat necrosis and inflammatory pseudotumor due to endoscopic tattooing of the colon with india ink. Gastrointest Endosc 1991; 37: 65-8.
187. Cannon-Albright LA, Bishop T, Samowitz W, DiSario JA, Lee R, Burt RW. Colonic polyps in an unselected population: prevalence, characteristics, and associations. Am J Gastroenterol 1994; 89: 827-31.
188. Kono S, Imanishi K, Shinchi K, Yanai F. Relationship of diet to small and large adenomas of the sigmoid colon. Jpn J Cancer Res 1993; 84: 13-19.
189. Hoff G, Moen IE, Trygg K, et al. Colorectal adenoma and food. Scand J Gastroenterol 1988; 23: 1253-8.
190. Hixson LJ, Earnest DL, Fennerty MB, Sampliner RE. NSAID effect on sporadic colon polyps. Am J Gastroenterol 1993; 88: 1652-6.
191. Hofstad B, Almendingen K, Vatn M, et al. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 1998; 59: 148-56.
192. Løvig T, Thorstensen L, Hofstad B, et al. Genetic and protein markers related to in situ growth and multiplicity in small sporadic colorectal adenomas. Scand J Gastroenterol 2003; 38: 298-306.
193. Almendingen K, Hofstad B, Vatn MH. Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas? Gut 2003; 52: 747-51.